Abiomed Inc. | Mutual Funds
Mutual Funds that own Abiomed Inc.
PRIMECAP Odyssey Growth Fund
1,756,100
3.91%
-73,700
5.3%
06/30/2018
PRIMECAP Odyssey Aggressive Growth Fund
1,388,873
3.1%
-373,000
5.01%
06/30/2018
Vanguard Total Stock Market Index Fund
1,059,431
2.36%
4,004
0.06%
07/31/2018
Vanguard Mid Cap Index Fund
999,007
2.23%
5,346
0.39%
07/31/2018
Vanguard 500 Index Fund
764,830
1.7%
726
0.07%
07/31/2018
Brown Capital Management - Small Company Fund
755,919
1.68%
0
5.65%
03/31/2018
Government Pension Fund - Global (The)
533,574
1.19%
56,997
0.03%
12/31/2017
SPDR S&P 500 ETF
464,625
1.03%
5,425
0.07%
09/06/2018
Vanguard Investment Series Plc - US Opportunities Fund
416,967
0.93%
-70,750
5.38%
06/30/2018
Vanguard Institutional Index Fund
408,817
0.91%
440
0.07%
07/31/2018
| Address |
22 Cherry Hill Drive
Danvers Massachusetts 01923
United States
|
|
Employees
|
- |
| Website |
http://www.abiomed.com |
| Updated |
07/08/2019 |
| ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded in 1981 and is headquartered in Danvers, MA. |
